Friday, September 26, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

Rowex Ltd. announces launch of Emazole Control 7s and 14s tablets

Karolina by Karolina
26 November 2019
in Product News
0

Rowex Ltd. is pleased to announce the launch of Emazole Control containing Esomeprazole, for the short-term treatment of reflux symptoms (heartburn, acid regurgitation) in adults, aged 18 and over.

BRAND NAME STRENGTH PACK SIZE LEGAL CATEGORY
Emazole Control 20 mg Gastro-resistant tablets 7 OTC
Emazole Control 20 mg Gastro-resistant tablets 14 OTC

For further information or to order contact the Rowex Telesales Team: Eugene, Jeanne Marie or Rita on 1800 304 400

Medicinal product not subject to medical prescription. For further information, SPC or to report adverse drug reactions, contact: Rowex Ltd., Bantry, Co. Cork, P75 V009 Freephone: 1800 304 400 Fax: 027 50417 E-mail: rowex@rowa-pharma.ie

Date of preparation: (11-19) CCF No: 22694

Tags: IPNIrish Pharmacy NewsRowex Ltd
Previous Post

New Irish pharma company Azure Pharmaceuticals launches with focus on medicine shortages

Next Post

Announcement from Dermal Laboratories – Capasal Shampoo

Next Post

Announcement from Dermal Laboratories - Capasal Shampoo

Irish Pharmacy Union Welcomes Publication of the Community Pharmacy Agreement 2025

Boots Kickstarts Winter Vaccination Season with Convenient and Comprehensive Services

23 September 2025
Irish Pharmacy Union Welcomes Publication of the Community Pharmacy Agreement 2025

Irish Pharmacy Union Welcomes Publication of the Community Pharmacy Agreement 2025

18 September 2025
Inizio appoints Ryan Quigley as its new Chief Executive Officer to lead its next phase of growth

Inizio appoints Ryan Quigley as its new Chief Executive Officer to lead its next phase of growth

17 September 2025

RECOMMENDED NEWS

Women who have experienced difficulties in pregnancy (eg diabetes, hypertension, premature labour) are more likely to be at risk of heart attack in later life.  

Women who have experienced difficulties in pregnancy (eg diabetes, hypertension, premature labour) are more likely to be at risk of heart attack in later life.  

2 years ago
Mastering the Digestive Health Category

Mastering the Digestive Health Category

1 year ago
Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

2 years ago
Asthma & Allergy Season – Top Picks for Summer Sufferers

Asthma & Allergy Season – Top Picks for Summer Sufferers

3 years ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN